The Dental Advisor has recognized TheraCal PT as a 2019 Clinical Problem Solver. Many offices have struggled with treating pediatric pulpotomy cases. TheraCal PT is BISCO’s newest product created specifically for pulpotomy treatment. It is a resin-modified, dual-cured biocompatible material that allows for an immediate restoration. After achieving hemostasis, place the material and light-cure for 10 seconds, then continue with the restoration. The pediatric patient no longer needs to sit still for 5 to 10 minutes with the medicaments in the tooth, saving everyone time.
TheraCal PT maintains tooth vitality by performing as a barrier and protectant of the dental pulpal complex. TheraCal PT’s chemical formulation consists of synthetic Portland Cement calcium silicate particles in a unique hydrophilic matrix, which facilitates calcium release. TheraCal PT is radiopaque, allowing for easy identification and differentiation from recurrent decay and other restorative materials. TheraCal PT’s physical properties resist breakdown and degradation, leading to a durable seal. TheraCal PT is also indicated for direct and indirect pulp capping (liner) and as a base.
As the newest member of the THERA Family, the material also releases calcium and has an alkaline pH.
To learn more and receive a special offer, visit https://info.bisco.com/introducing-theracal-pt or phone BISCO at (800) 247-3368.